Related Experiment Video
Updated: Jul 24, 2025

Visualization, Quantification, and Mapping of Immune Cell Populations in the Tumor Microenvironment
Published on: March 25, 2020
Interobserver Variability in Contouring Hepatocellular Carcinoma at a Tertiary Center
Carolina DE LA Pinta1, Juan David García2, David Sevillano2
1Radiation Oncology Department, Ramón y Cajal University Hospital, IRYCIS, Alcalá University, Madrid, Spain.
Computed tomography (CT) is reproducible for well-defined liver tumors, but magnetic resonance imaging (MRI) can complement CT for unclear cases in hepatocellular carcinoma radiotherapy. Interobserver variability in tumor delineation is notable.
Area of Science:
- Radiology
- Oncology
- Medical Imaging
Background:
- Optimal imaging for hepatocellular carcinoma (HCC) gross tumor volume (GTV) delineation in radiotherapy remains undefined.
- Magnetic resonance imaging (MRI) is hypothesized to offer superior visualization compared to computed tomography (CT).
Purpose of the Study:
- To compare the accuracy of GTV delineation for liver stereotactic radiotherapy using MRI versus CT.
- To evaluate interobserver agreement in GTV delineation of HCC.
Main Methods:
- Eight radiation oncologists delineated GTVs from CT and MRI scans of five HCC patients.
- GTV volumes and interobserver variability were compared between CT and MRI datasets.
Main Results:
- Median GTV volume on MRI (2.4 cm³) was not significantly different from CT (3.5 cm³).
- MRI delineated larger or equal GTV volumes in two cases.
- Interobserver variance and standard deviation were minor for both CT and MRI.
Conclusions:
- CT is reproducible for well-defined HCC tumors.
- MRI can be a complementary tool when CT delineation is unclear.
- Significant interobserver variability in HCC target delineation warrants attention.
More Related Videos
09:49Dual-phase Cone-beam Computed Tomography to See, Reach, and Treat Hepatocellular Carcinoma during Drug-eluting Beads Transarterial Chemo-embolization
Published on: December 2, 2013
08:15A Hepatocellular Cancer Patient-Derived Organoid Xenograft Model to Investigate Impact of Liver Regeneration on Tumor Growth
Published on: February 2, 2024